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ABSTRACT: Genes for ﬁve diﬀerent 5-HT3 receptor subunits have
been identiﬁed. Most of the subunits have multiple isoforms, but two
isoforms of the B subunits, brain-type 1 (Br1) and brain-type 2 (Br2) are
of particular interest as they appear to be abundantly expressed in human
brain, where 5-HT3B subunit RNA consists of approximately 75% 5-
HT3Br2, 24% 5-HT3Br1, and <1% 5-HT3B. Here we use two-electrode
voltage-clamp, radioligand binding, ﬂuorescence, whole cell, and single
channel patch-clamp studies to characterize the roles of 5-HT3Br1 and 5-
HT3Br2 subunits on function and pharmacology in heterologously
expressed 5-HT3 receptors. The data show that the 5-HT3Br1
transcriptional variant, when coexpressed with 5-HT3A subunits, alters
the EC50, nH, and single channel conductance of the 5-HT3 receptor, but
has no eﬀect on the potency of competitive antagonists; thus, 5-
HT3ABr1 receptors have the same characteristics as 5-HT3AB receptors.
There were some diﬀerences in the shapes of 5-HT3AB and 5-HT3ABr1 receptor responses, which were likely due to a greater
proportion of homomeric 5-HT3A versus heteromeric 5-HT3ABr1 receptors in the latter, as expression of the 5-HT3Br1
compared to the 5-HT3B subunit is less eﬃcient. Conversely, the 5-HT3Br2 subunit does not appear to form functional channels
with the 5-HT3A subunit in either oocytes or HEK293 cells, and the role of this subunit is yet to be determined.
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5-HT3 receptors are members of the Cys-loop family of ligand-
gated ion channels that are responsible for fast excitatory and
inhibitory synaptic transmission in the central and peripheral
nervous systems. Other members of this family include the
nACh, GABA, and glycine receptors, all of which share a
common structural arrangement and are targets for a range of
clinically important drugs.1−4
Cys-loop receptors consist of ﬁve subunits that surround a
central ion-conducting pore. Each subunit can be divided into
three functionally distinct regions that are termed the
intracellular, transmembrane, and extracellular domains. The
intracellular domain, whose structure is not yet known, is
responsible for post-translational modulation by intracellular
molecules and plays a role in channel conductance.3,5 The
transmembrane domain consists of four membrane-spanning α-
helices (M1−M4); M2 lines the pore, enabling ions to pass
through the channel. In 5-HT3 receptors, the pore is cation
selective, and its opening results in a rapidly activating and then
desensitizing inward current that depolarizes the cell. The
extracellular domain contains the ligand binding sites for
agonist and competitive antagonists and these are formed by
the convergence of six amino acid loops at the interface of two
adjacent subunits. Three loops (A−C) arise from the principal
subunit and three (D−F) from the complementary subunit.
The amino acids responsible for interacting with ligands vary
according to the ligand and receptor being studied, but all
binding pockets possess three to ﬁve aromatic residues that
contribute to an “aromatic box” which is important for binding
ligands.
To date, genes for ﬁve 5-HT3 receptor subunits have been
identiﬁed (5-HT3A−5-HT3E) in humans.6 Only 5-HT3A
subunits can form functional homomeric receptors, and the
structure of the mouse 5-HT3A receptor has recently been
solved to high resolution.7 The other subunits can combine
with 5-HT3A to form heteromeric complexes, but, apart from
receptors expressing 5-HT3A and 5HT3B subunits (5-HT3AB
receptors), these have not been extensively investigated.8−10
Most of the subunits have multiple isoforms, but two isoforms
of the 5-HT3B subunits, brain-type 1 and brain-type 2 (called
here 5-HT3Br1 and 5-HT3Br2 rather than 5-HT3BBr1/2), are
of particular interest as their RNAs are abundantly expressed in
human brain.11 These authors reported that in brain less than
1% of the 5-HT3B subunit RNA coded for the conventional 5-
HT3B subunit, while the remaining B-subunit RNA was
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accounted for by approximately 75% 5-HT3Br2 and 24% 5-
HT3Br1. There is therefore the potential that 5-HT3AB
receptors in the brain have distinct properties to those in
other regions. As 5-HT3 receptor-selective agents have a range
of therapeutic applications it is important to better understand
the consequences of incorporating these subunits on the
pharmacology and physiology of these receptors.
The aim of this study was to assess the functional role of 5-
HT3AB receptors containing 5-HT3Br1 or 5-HT3Br2 subunits,
which diﬀer only in their N-terminal sequences (Figure 1)
compared to the originally described 5-HT3B subunit. We do
this using a combination of two-electrode voltage-clamp,
radioligand binding, ﬂuorescence, and whole cell and single
channel patch-clamp studies.
■ RESULTS AND DISCUSSION
Characterization of 5-HT3A and 5-HT3AB Receptors.
Application of 5-HT to Xenopus oocytes expressing homomeric
or heteromeric receptors produced rapidly activating inward
currents that desensitized over the time-course of the
application (Figure 2). The shape of the responses elicited by
5-HT3A and 5-HT3AB receptors diﬀered due to faster
desensitization of the latter. Concentration−response curves
for 5-HT3A and 5-HT3AB receptors also showed diﬀerences in
5-HT EC50, which was increased in 5-HT3AB compared to 5-
HT3A receptors, and Hill slope, which was reduced (Table 1,
Figure 2) as previously published.8−10 Similar diﬀerences in
EC50 and nH were observed for receptors expressed in HEK293
cells, with functional responses measured using a ﬂuorescent
membrane potential sensitive dye; EC50 was increased and nH
decreased in 5-HT3AB compared to 5-HT3A receptors. Here
again there were diﬀerences in the shape of the responses: 5-
HT3A receptor responses peaked and returned toward baseline
over the course of the experiment, while 5-HT3AB responses
peaked more slowly and only decreased toward baseline at
lower 5-HT concentrations (Figure 3).
Characterization of 5-HT3ABr1 Receptors in Oocytes.
Coexpression of 5-HT3Br1 with 5-HT3A subunits produced
currents in Xenopus oocytes with concentration−response
parameters that were similar to 5-HT3AB receptors. This was
expected as the amino acid composition of the 5-HT3Br1
Figure 1. Alignment of the N-terminal region of 5-HT3B, 5-HT3Br1, and 5-HT3Br2 subunits. 5HT3Br1 subunits diﬀer from 5-HT3B subunits only
in the extreme N-terminus, while 5HT3Br2 has ∼100 fewer amino acids and is missing the β1 and β2/loop D regions. Diﬀerences in the subunits are
due to alternative splicing so the remaining sequences are identical.
Figure 2. Traces of macroscopic currents from 5-HT3 receptors
expressed in oocytes measured using voltage clamp electrophysiology.
Typical examples of current traces over a range of 5-HT
concentrations for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and 5-HT3ABr2
receptors from the same batch of oocytes are shown. There are distinct
diﬀerences in the shapes of all the currents.
Table 1. Parameters Derived from 5-HT-Induced
Macroscopic Responses of 5-HT3 Receptors Expressed in
Oocytes
receptor pEC50 (M) mean ± SEM nH n
5-HT3A 5.76 ± 0.02 2.6 6
5-HT3AB 4.55 ± 0.04
a 1.0 7
5-HT3ABr1 5.09 ± 0.06
a 1.0 8
5-HT3ABr2 5.48 ± 0.04
b 1.9 6
aSigniﬁcantly diﬀerent from 5-HT3A receptors, p < 0.05.
bSigniﬁcantly
diﬀerent from 5-HT3AB receptors, p < 0.05
Figure 3. Responses from 5-HT3 receptors expressed in HEK293 cells
measured using a ﬂuorescent membrane potential sensitive dye.
Typical examples of 5-HT-induced responses over a range of 5-HT
concentrations for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and 5-HT3ABr2
receptors are shown. The response proﬁles of 5-HT3A and 5-HT3AB
receptors are diﬀerent, with 5-HT3ABr1 receptor responses similar to
5-HT3AB receptor responses, and 5HT3Br2 receptor responses similar
to 5-HT3A receptor responses. F = arbitrary ﬂuorescent units.
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subunit is very similar to that of the 5-HT3B subunit, with the
only diﬀerence being a region at the extreme N-terminus of the
subunit (Figure 1). This region is likely to be predominantly, if
not solely, part of the signal sequence, and thus is not likely to
be expressed in the mature protein. However, the shape of the
responses in 5-HT3ABr1 receptors diﬀered from those in 5-
HT3AB receptors, being somewhat intermediate between those
of 5-HT3A and 5-HT3AB receptors (Figure 2), with fast
desensitization at high 5-HT concentration but slower
desensitization at low concentrations. These diﬀerences likely
arise as these cells can express both homomeric (5-HT3A) and
heteromeric receptors (5-HT3AB/Br1), and the proportions of
these may diﬀer depending on which B subunit is being
expressed. It is also possible that diﬀerential B subunit
expression could cause diﬀerent stoichiometries, and diﬀerent
characteristics, as is the case in certain nACh receptors,12
although there is currently no evidence for this.
Characterization of 5-HT3ABr1 Receptors in HEK Cells.
Coexpression of 5-HT3A and 5-HT3Br1 subunits in HEK cells
analyzed using membrane potential ﬂuorescent dye revealed
shapes of 5-HT-induced responses that were not signiﬁcantly
diﬀerent to those of 5-HT3AB receptors (Figure 3). The 5-
HT3ABr1 concentration−response curves were right shifted
and had lower Hill slopes when compared to 5-HT3A receptors,
consistent with voltage clamp measurements in oocytes (Table
2).
The 5-HT3Br1 subunit, however, was expressed and/or
incorporated into functional receptors over a diﬀerent time
course and concentration range when compared to the 5-HT3B
subunit: higher concentrations and a longer period after
transfection were needed to obtain similar eﬀects. Figure 4
shows the eﬀects on receptor parameters determined 2 or 3
days post transfection. Analysis of data obtained 2 days post
transfection with 2 or 20 ng 5-HT3B subunit cDNA (both
combined with 20 ng 5-HT3A subunit cDNA) revealed
receptor characteristics that were consistent with 5-HT3AB
receptors, but such characteristics were not apparent in cells
transfected with 5-HT3Br1 subunit cDNA until at least 3 days
post transfection and required >20 ng 5-HT3Br1 subunit
cDNA. These data show that the signal sequence has a
signiﬁcant eﬀect on expression and/or subsequent incorpo-
ration of the 5-HT3Br1 subunit into functional receptors, and
support the expression hypothesis proposed above (diﬀerent
relative expression levels of homomeric and heteromeric
receptors) to explain the diﬀerent traces in 5-HT3AB and 5-
HT3ABr1 receptors. Given these data, a study of the levels of
expression of the 5-HT3Br1 subunit protein in brain tissues
would be worthwhile, as the data showing high levels of 5-
HT3Br1 subunit RNA in neurones may not provide an accurate
picture of the relative proportions of diﬀerent types of 5-HT3
receptor subunits being expressed.
Radioligand binding with the 5-HT3−receptor selective
antagonist [3H]granisetron revealed no diﬀerences in the Kd
values of 5-HT3AB and 5-HT3ABr1 receptors, and these were
also similar to values from 5-HT3A receptors (Table 2). We
also determined Ki values for a range of competitive
antagonists, and all competed with similar aﬃnities with a
rank order of potency of palonosetron > granisetron > MDL-
72222 > mCPBG > d-TC (Figure 5). These data are consistent
with previous studies on 5-HT3A and 5-HT3AB receptors that
have demonstrated similar antagonist aﬃnities for a range of
compounds, despite some biophysical diﬀerences between
Table 2. Parameters Derived from 5-HT3 Receptors Expressed in HEK293 Cells Using a Membrane Potential Dye or
Radioligand Bindinga
parameters from functional data
receptor pEC50 (M) nH Kd (nM) from [
3H]granisetron binding data
5-HT3A 6.56 ± 0.02 3.6 ± 0.8 0.33 ± 0.02
5-HT3AB 5.81 ± 0.06
b 1.3 ± 0.2b 0.25 ± 0.08
5-HT3ABr1 5.79 ± 0.08
b 1.5 ± 0.3b 0.35 ± 0.09
5-HT3ABr2 6.43 ± 0.06
c 2.9 ± 0.4c 0.41 ± 0.11
aData = mean ± SEM, n = 3−8. bSigniﬁcantly diﬀerent from 5-HT3A receptors, p < 0.05.
cSigniﬁcantly diﬀerent from 5-HT3AB receptors, p < 0.05
Figure 4. Appearance of 5-HT3AB receptor characteristics diﬀer
following transfection with 5-HT3B or 5-HT3Br1 subunits. Cells were
transfected with 5-HT3A subunit cDNA (20 ng per well) and various
amounts of 5-HT3B or 5-HT3Br1 subunit DNA, and incubated for 2
(A) or 3 (B) days. Higher EC50 and lower nH values (i.e., 5-HT3AB
receptor characteristics) were observed in cells incubated for 2 days
with 2 and 20 ng of 5-HT3B subunit cDNA, but those transfected with
0.2 ng of cDNA had responses with characteristics consistent with
homomeric 5-HT3A receptors. Cells transfected with 200 ng of 5-
HT3BR1 subunit cDNA had 5-HT3AB receptor characteristics after 3
days of incubation. Responses with characteristics consistent with
homomeric 5-HT3A receptors were observed for cells transfected with
2 or 20 ng of cDNA, and for cells incubated for 2 days (data not
shown). Data = mean ± SEM, n = 3−6;*signiﬁcantly diﬀerent from 5-
HT3A receptor responses.
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homomeric and heteromeric receptors. This similarity can be
readily explained if the binding site for these ligands is at an
interface between two adjacent 5-HT3A subunits, which is
consistent with the reduced Hill slope of 5-HT concentration−
response curve at heteromeric receptors, and our previous
ﬁndings that mutations to residues in either the principal or
complementary face of the 5-HT3B-subunit binding site do not
alter ligand binding.13 Indeed there is good evidence from
FRET studies that the orthosteric binding site is located
between two adjacent 5-HT3A subunits in both 5-HT3A and 5-
HT3AB receptors.
14
To further probe any diﬀerences between 5-HT3AB and 5-
HT3ABr1 receptors we explored their single channel currents.
Single-channel recordings from cell-attached patches of
HEK293 cells expressing 5-HT3AB and 5-HT3ABr1 receptors
(1:3 A:B or Br1 ratio) in the presence of 10 μM 5-HT revealed
that activation occurred in bursts composed of closely spaced
openings separated by brief closed periods. The mean
amplitude of single channel openings at −70 mV was 1.95 ±
0.06 pA and 2.17 ± 0.15 pA for 5-HT3AB and 5-HT3ABr1
receptors respectively (n = 3), and increased with the decrease
of membrane potential (2.9 ± 0.2 and 3.2 ± 0.3 pA,
respectively, at −100 mV; Figure 6). The relationship between
membrane potential and mean amplitude of the events yielded
an estimated conductance of 30 ± 1.2 pS and 33 ± 1.1 pS for 5-
HT3AB and 5-HT3ABr1 receptors, respectively (Figure 7). For
both receptors, open time histograms were ﬁtted by two
exponential components with no signiﬁcant diﬀerences in the
mean duration of each component (Figure 6). The mean
durations of both components at −100 mV were 3.9 ± 0.9 ms
and 0.14 ± 0.05 ms for 5-HT3AB (n = 6), and 3.6 ± 0.6 ms and
0.11 ± 0.03 ms for 5-HT3ABr1 (n = 4) (p > 0.1). In addition,
the mean burst duration did not diﬀer between 5-HT3AB (13.5
± 4.0 ms, n = 6) and 5-HT3ABr1 receptors (14.2 ± 5.20 ms, n
= 4) (p > 0.1). Thus, the data show there are no signiﬁcant
diﬀerences between single-channel properties of 5-HT3AB and
5-HT3ABr1 receptors.
Characterization of 5-HT3ABr2 Receptors in Oocytes.
The shape of the responses in oocytes following coinjection of
mRNA for 5-HT3A and 5-HT3Br2 subunits was again
somewhat intermediate between those of 5-HT3A and 5-
HT3AB receptors, although parameters obtained from concen-
tration−response curves were not signiﬁcantly diﬀerent to
Figure 5. Potencies of ligands at diﬀerent 5-HT3 receptors expressed
in HEK293 cells. The Ki values of a range of competitive 5-HT3
receptor ligands were not signiﬁcantly diﬀerent for all the diﬀerent
subtypes. Data = mean ± SEM, n = 3−6.
Figure 6. Single-channel currents of 5-HT3AB and 5-HT3ABr1 receptors expressed in HEK293 cells. Single channels activated by 10 μM 5-HT were
recorded from cells transfected with 5-HT3A together with 5-HT3B or 5-HT3Br1 subunits (1:3 A:B or Br1 ratio; total DNA, 4 μg/dish). Recordings
were made 3 days after transfection. Channels are shown as upward deﬂections at diﬀerent membrane potentials and two diﬀerent temporal scales
for each receptor. Filter: 10 kHz. Representative amplitude histograms at diﬀerent membrane potentials are shown. At the bottom, representative
open- and burst-duration histograms for each receptor at −100 mV are shown.
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those obtained from 5-HT3A receptors. These data could
indicate that the 5-HT3Br2 subunit is being incorporated into
receptors, but has no eﬀect on receptor parameters. To test
this, we examined the potency of picrotoxinin. This compound
acts in the pore and has diﬀering potencies at 5-HT3A and 5-
HT3AB receptors (IC50s of 11 and 62 μM respectively) due to
the diﬀerent pore lining residues contributed by the 5-HT3B
(and similarly the 5-HT3Br1 and 5-HT3Br2) subunits.15 Here
picrotoxinin had an IC50 of 17 μM (pIC50 = 4.77 ± 0.14, n = 3),
which is not signiﬁcantly diﬀerent from the value obtained for
5-HT3A receptors (pIC50 = 4.97 ± 0.12, n = 13), suggesting the
5-HT3Br2 subunit was not part of the functional receptor.
Characterization of 5-HT3ABr2 Receptors in HEK Cells.
Coexpression of 5-HT3A and 5-HT3Br2 receptor subunits in
HEK cells analyzed using membrane potential ﬂuorescent dye
revealed concentration response parameters and shapes of
traces that were indistinguishable from those of 5-HT3A
receptors (Figure 3). Macroscopic currents measured in the
whole cell conﬁguration from cells transfected with 5-HT3A
and 5-HT3Br2 subunits (1:9 ratio) were similar to those of 5-
HT3A receptors and clearly diﬀerent to those of 5-HT3AB
receptors (Figure 8).
Moreover, despite the detection of whole-cell macroscopic
currents in 5-HT3ABr2 transfected cells, no single channel
events were detected in 30 diﬀerent patches from green cells
and two diﬀerent transfections (ratios 1:3 and 1:9 of 5-
HT3A:5-HT3Br2 subunits) (Figure 8). These data are
therefore consistent with functional expression of solely
homomeric 5-HT3A receptors, whose conductance is too low
to allow detection of single channel openings.16 It has been
shown that only after the introduction of the triple QDA
mutation at determinants of ion conductance of the 5-HT3A
subunit, which mimics the amino acids found in the 5-HT3B
subunit, single-channel openings of 5-HT3A receptors can be
detected under the present recording conditions.16−18 Incor-
poration of even one 5-HT3Br2 subunit into receptors should
permit the detection of such events, as this subunit possesses
the high-conductance triple QDA motif that can be readily
detected even when only a single subunit is present.19,20
This apparent lack of incorporation of the 5-HT3Br2 subunit
into functional heteromeric receptors is likely to be due to its
unusual sequence: this subunit is missing the β1-β2 loop and
loop D, which are essential for gating.21 The considerable
abundance of 5-HT3Br2 mRNA in the brain, however, suggests
it is important.11 This subunit may therefore have some other
role, and warrants further investigation.
■ CONCLUSION
This study demonstrates that the 5-HT3Br1 transcriptional
variant of the 5-HT3B subunit can contribute to the functional
properties of heteromeric receptors in a similar manner to the
Figure 7. Current−voltage (IV) relationships for 5-HT3AB and 5-
HT3ABr1 receptors expressed in HEK293 cells. Data corresponds to
the mean amplitude (I) ± SD for at least 160 opening events from
three diﬀerent cells, transfected as in Figure 6, for each condition. The
mean amplitude was obtained from the corresponding amplitude
histogram. The conductance was obtained from the slope of the curve.
Data are not signiﬁcantly diﬀerent (p > 0.05).
Figure 8. Macroscopic and single-channel recordings from HEK293
cells cotransfected with 5-HT3A or in combination with 5-HT3B, 5-
HT3Br1, or 5-HT3Br2 subunits. Representative traces of macroscopic
(top of each panel) and single-channel currents (bottom of each
panel) from cells transfected with only 5-HT3A or together with 5-
HT3Br2 or 5-HT3B subunits are shown (subunit ratio 1:3 for A:B and
A:Br1, and 1:9 for A:Br2, total DNA was 4 μg/dish). Macroscopic
currents were recorded in the whole cell conﬁguration at a holding
potential of −50 mV and were elicited by a pulse of 100 μM 5-HT
(gray bar). Single-channel currents were recorded from cell-attached
patches at −100 mV in the presence of 10 μM 5-HT. Channel
openings are shown as upward deﬂections.
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originally characterized 5-HT3B subunit, altering the EC50, nH,
and single channel conductance of the 5-HT3A receptor. Its
expression levels, however, diﬀer signiﬁcantly from those of the
canonical 5-HT3B subunits in heterologous systems. Con-
versely the 5-HT3Br2 subunit does not form functional
channels with the 5-HT3A subunit in either oocytes or HEK
cells. Its physiological role is yet to be determined.
■ METHODS
Materials. All cell culture reagents were obtained from Gibco
(Invitrogen Ltd., Paisley, U.K.), except fetal calf serum which was from
Labtech International (Ringmer, U.K.). Human 5-HT3A (accession
number: P46098) and 5-HT3B (O95264) receptor subunit cDNA was
kindly gifted by Prof J. A. Peters (University of Dundee, U.K.). 5-
HT3Br1 and 5-HT3Br2 subunit cDNAs were generated by
Quikchange mutagenesis.
Oocyte Maintenance. Xenopus laevis oocyte-positive females were
purchased from NASCO (Fort Atkinson, WI) and maintained
according to standard methods. Harvested stage V−VI Xenopus
oocytes were washed in four changes of Ca-free ND96 (96 mM NaCl,
2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5), defolliculated in 1.5
mg mL−1 collagenase Type 1A for approximately 2 h, washed again in
four changes of ND96, and then stored in ND96 containing 2.5 mM
sodium pyruvate, 50 mM gentamycin, and 0.7 mM theophylline.
HEK293 Cell Culture. Human embryonic kidney (HEK) 293 cells
were maintained on 90 mm tissue culture plates at 37 °C and 7% CO2
in a humidiﬁed atmosphere. They were cultured in DMEM:F12 with
GlutaMAX I media (Dulbecco’s modiﬁed Eagle’s Medium/Nutrient
Mix F12 (1:1), Invitrogen, Paisley, U.K.) containing 10% fetal calf
serum. Cells in 90 mm dishes were transfected using polyethylenimine
(PEI). Then 30 μL of PEI (1 mg/mL), 4 μL of cDNA (1 mg/mL) and
1 mL of DMEM were incubated for 10 min at room temperature,
added dropwise to a 80−90% conﬂuent plate, and incubated for 2−3
days. For Flexstation studies, cells were transferred to 96-well plates
and allowed to adhere overnight before use.
Receptor Expression. cDNA was cloned into pGEMHE for
oocyte expression, and pcDNA3.1 (Invitrogen, Paisley, U.K.) for
expression in HEK 293 cells. Mutagenesis (Figure 1) was performed
using QuikChange (Agilent Technologies Inc., Santa Clara, CA).
cRNA was in vitro transcribed from linearized pGEMHE cDNA
template using the mMessage mMachine T7 Transcription kit
(Ambion, Austin, TX). 5-HT3A was linearized with SphI and 5-
HT3B cDNA with NheI. Stage V and VI oocytes were injected with 50
nL of ∼400 ng μL−1 cRNA, and currents were recorded 1−4 days
postinjection. Ratios of 1:3 (5-HT3A:5-HT3B/5-HT3Br1/5-HT3Br2)
were used for the expression of heteromeric receptors unless otherwise
stated. These levels were previously found to be optimal for 5-HT3AB
receptor expression, as ratios ≤1:1 resulted in more 5-HT3A receptor-
like responses and ≥1:10 showed poorer total receptor expression.
Fluorometric Analysis. This was as previously described.22 In
brief, ﬂuorescent membrane potential dye (Membrane Potential Blue
kit, Molecular Devices) was diluted in Flex buﬀer (10 mM HEPES,
115 mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM
glucose, pH 7.4) and 100 μL added to each well of transfected cells.
The cells were incubated at 37 °C for 45 min, and then ﬂuorescence
was measured in a FlexStation (Molecular Devices) at 2 s intervals for
200 s. 5-HT (Sigma) was added to each well after 20 s. Analysis and
curve ﬁtting was performed using Prism (GraphPad Software, San
Diego, CA, www.graphpad.com).
TEVC Electrophysiology. Using two electrode voltage-clamp,
Xenopus oocytes were clamped at −60 mV using an OC-725 ampliﬁer
(Warner Instruments, Hamden, CT), Digidata 1322A, and the
Strathclyde Electrophysiology Software Package (Department of
Physiology and Pharmacology, University of Strathclyde, UK).
Currents were recorded at a frequency of 5 kHz and ﬁltered at 1
kHz. Microelectrodes were fabricated from borosilicate glass
(GC120TF-10, Harvard Apparatus, Edenbridge, Kent, U.K.) using a
one stage horizontal pull (P-87, Sutter Instrument Company, Novato,
CA) and ﬁlled with 3 M KCl. Pipet resistances ranged from 1.0 to 2.0
MΩ. Oocytes were perfused with saline at a constant rate of 12 mL
min−1. Drug application was via a simple gravity fed system calibrated
to run at the same rate. Extracellular saline contained (mM), 96 NaCl,
2 KCl, 1 MgCl2, and 5 mM HEPES; pH 7.4 with NaOH).
Concentration−response data for each oocyte was normalized to
the maximum current for that oocyte, and analysis and curve ﬁtting
was performed using Prism.
Whole-Cell Patch-Clamp Electrophysiology. Macroscopic
current recordings were recorded in the whole-cell conﬁguration
essentially as described before.17 For whole-cell recordings, the
perfusion system consisted of solution reservoirs, manual switching
valves, a solenoid-driven pinch valve, and two tubes (inner diameter,
0.3 mm) oriented at 90° inserted into the culture dish (modiﬁed from
ref 23). One tube contained extracellular solution (ECS) without
agonist (normal solution), and the other contained ECS with of 5-HT
(test solution). A series of 1.5 s pulses of ECS containing 100 μM 5-
HT were applied at 15 s intervals. The pipet solution contained 134
mM KCl, 5 mM EGTA, 1 mM MgCl2, and 10 mM HEPES, pH 7.3.
The extracellular solution contained 150 mM NaCl, 5.6 mM KCl, 0.5
mM CaCl2, and 10 mM HEPES, pH 7.3. Macroscopic currents were
recorded at an applied potential of −50 mV, ﬁltered at 5 kHz, and
digitized at 20 kHz. Data analysis was performed using the IgorPro
software (Wavemetrics). For each experiment, three to ﬁve individual
records were aligned at the point at which the current reached 50% of
maximum, and expressed as their average. The solution exchange time
was estimated by placing an open pipet at the cell position, and
switching from normal bath solution to a diluted (1:1 with water) bath
solution. Typical times varied between 1 and 2 ms.
Single-Channel Patch-Clamp Recordings. Single-channel re-
cordings were obtained in the cell-attached patch conﬁguration
essentially as described before.17 The bath and pipet solutions
contained 142 mM KCl, 5.4 mM NaCl, 0.2 mM CaCl2, and 10 mM
HEPES, pH 7.4. Single-channel currents were recorded and low-pass
ﬁltered to 10 kHz using an Axopatch 200 B patch-clamp ampliﬁer
(Molecular Devices), digitized at 5 μs intervals, and detected by the
half a mplitude threshold criterion using the program TAC (Bruxton
Corporation). Open-time histograms were ﬁtted by the sum of
exponential functions by maximum likelihood using the program
TACFit (Bruxton Corporation). Bursts were identiﬁed as a series of
closely separated openings (more than ﬁve) preceded and followed by
closings longer than a critical duration. The critical time was taken as
the point of intersection of the second and the third component in the
closed-time histogram for bursts (τc
b). Typically, τc
b were between 0.2
and 0.6 ms. Burst duration was obtained from the longest duration
component of the open-time histogram constructed with the critical
time for deﬁning bursts.
Radioligand Binding. Transfected HEK 293 cells were scraped
into 1 mL of ice-cold HEPES buﬀer (10 mM, pH 7.4) and frozen.
After thawing, they were washed with HEPES buﬀer and resuspended,
and then 50 μg of cell membranes was incubated in 0.5 mL of HEPES
buﬀer containing 1 nM [3H]granisetron (∼Kd) in a total volume of
500 μL. Nonspeciﬁc binding was determined using 1 mM quipazine or
10 μM d-tubocurarine, giving the same result. For competition binding
(8 point), reactions were incubated for at least 1 h at 4 °C. Reactions
were terminated by vacuum ﬁltration using a Brandel cell harvester
onto GF/B ﬁlters presoaked in 0.3% polyethylenimine. Radioactivity
was determined by scintillation counting using a Beckman BCLS6500
instrument (Fullerton, CA). Individual competition binding experi-
ments were analyzed by iterative curve ﬁtting using Prism.
Statistical Analysis. Statistical analysis was performed using Prism
using Student’s t test or one-way ANOVA as appropriate, and p < 0.05
was taken as statistically signiﬁcant.
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